Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Executive Record

Sushil Patel

Chief executive: Replimune Group, Inc. (1 Apr 2024 to present)

13commitments announced
7with a clear outcome
6met on time
–rate shown after 15 outcomes

Commitments are credited to the chief executive in office on the day they were announced. Where a deadline fell after the leader left, the entry is marked. Sources for each leadership change: Replimune Group, Inc. filing.

Commitments announced under Sushil Patel

Replimune Group, Inc.announced 30 Jul 2026 Report overall survival data for the IGNYTE-3 randomized confirmatory trial Open31 Dec 2030
Replimune Group, Inc.announced 3 Feb 2026 Report clinical trial data for RP2 monotherapy Open31 Dec 2026
Replimune Group, Inc.announced 3 Feb 2026 Transition the REVEAL study of RP2 to Phase 3 Open31 Mar 2027
Replimune Group, Inc.announced 12 Jan 2026 Expand into 350 additional accounts Being checked12 Oct 2026
Replimune Group, Inc.announced 12 Jan 2026 Conduct interim OS analysis for the IGNYTE-3 study Open31 Dec 2027
Replimune Group, Inc.announced 6 Nov 2025 Publish data from the ARTACUS Phase 2 trial Open31 Dec 2026
Replimune Group, Inc.announced 7 Aug 2025 Dose the first patient in the RP2 biliary tract cancer cohort Met31 Dec 2025
Replimune Group, Inc.announced 13 Jun 2024 Launch RP1 in skin cancers Not met31 Dec 2025
Replimune Group, Inc.announced 6 Jun 2024 Enroll the first patient in the IGNYTE-3 Phase 3 confirmatory study Met30 Sep 2024
Replimune Group, Inc.announced 6 Jun 2024 Submit the Biologics License Application (BLA) Met31 Dec 2024
Replimune Group, Inc.announced 3 Jun 2024 Report primary analysis results by independent central review from the IGNYTE anti-PD-1 failed melanoma cohort Met30 Jun 2024
Replimune Group, Inc.announced 16 May 2024 Enroll first patient in Phase 3 confirmatory trial of RP1 Met31 Dec 2024
Replimune Group, Inc.announced 16 May 2024 Initiate Phase 2 clinical trial of RP2 in HCC Met31 Dec 2024

Is this record wrong, or are you Sushil Patel? Add a statement or ask for a correction.

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.